Anika Therapeutics Inc (ANIK)

EBITDA Margin

14.98%

Quarterly · Period ending:

ANIK logo

ANIK EBITDA Margin

Latest reported14.98%
ANIK Quarterly EBITDA Margin (-400.00% → 14.98%)
High-resolution chart · PNG

ANIK ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
14.9801%
-11.5291%
6.8006%
-2.9946%
-9.0365%
-8.7015%
-2,056.5116%
-65.6027%
2.7438%
-5.9423%
4.6147%
-8.4336%
1.0835%
-22.3157%
-6.8775%
-4.6369%
1.0692%
0.1717%
-12.7523%
3.6068%
-2.5351%
-0.1575%
-7.85%
-0.8614%
-5.3524%
9.8229%
21.275%
45.678%
44.7663%
31.3635%
41.6939%
37.6526%
41.551%
-29.4582%
36.7293%
42.1976%
55.9859%
38.5701%
47.6815%
56.4776%
54.2794%
52.2865%
58.3951%
55.4663%
54.2653%
41.3543%
56.8344%
52.1244%
62.3046%
73.7111%
55.4298%
50.0087%
49.7206%
39.8637%
50.8275%
26.4723%
31.2558%
21.3295%
32.3942%
26.1021%
22.7843%
4.7427%
22.7074%
14.9802%
12.4419%
9.448%
38.1489%
18.6815%
16.1993%
8.2537%
17.8382%
14.4646%
9.833%
8.8405%
24.9562%
25.9827%
21.8275%
22.5543%
16.3155%
29.1477%
24.5821%
16.2009%
17.801%
40.167%
29.6581%
26.2515%
33.6468%
26.4086%
23.3152%
19.6222%
21.779%
10.602%
3.8276%
-7.7128%
21.3949%
-21.4301%
-27.6902%
-66.781%
-7.7242%
-35.5021%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.